Los Angeles, CA – A patent infringement lawsuit was filed by Neurographix, an exclusive licensee of the patent at issue, in the Federal District Court in Los Angeles, accusing Pasadena based Oak Tree Medical Corporation of infringing on the licensed patent. The University of Washington is the owner by assignment of the invention covered by U.S. Patent No. 5,560,360, entitled “Image Neurography and Diffusion Anisotropy Imaging.” Pursuant to a first licensing agreement, the University of Washington granted an exclusive license to the ‘360 patent to the Washington Research Foundation. The foundation, in turn, granted an exclusive license to the ‘360 patent to Neurografix.
The complaint alleges that defendants Oak Tree Medical and Dr. Jay Tsuruda are infringing the ‘360 patent by making, using, importing, offering for sale, and/or selling products and services which provide peripheral nerve MRI imaging services. It is alleged that “Defendants knowingly, willfully, and deliberately infringed and, on information and belief, continue to infringe the ‘360 Patent in conscious disregard of [Neurografix’s] and [Washington Research Foundation’s] rights, making this case exceptional within the meaning of 35 U.S.C. §285 and justifying treble damages pursuant to 35 U.S.C. §284.” Plaintiffs also seek both preliminary and permanent injunctions against further alleged infringement. The case is titled Neurografix et al. v. Oak Tree Medical Corporation et al., CV 08-02923 CAS (C.D. Cal. 2008).
Los Angeles Intellectual Property Trademark Attorney Blog


Icon alleges that both defendants infringe on both of the patents through the manufacturing, importing, and/or sale of the Octane Fitness Q47 Series exercise device. “The conduct of [Defendants] as set forth hereinabove gives rise to a claim for infringement of the Asserted Patents, pursuant to at least 35 U.S.C. §§ 271 and 281. Icon also asserts that it “is entitled to injunctive and monetary relief against [defendants], pursuant to 35 U.S.C. §§ 283, 284, and 285. The case is titled Icon Health & Fitness, Inc. v. Octane Fitness, LLC, et al., SACV 08-00437 CJC (C.D. Cal. 2008).
The complaint alleges that defendant “Blue Sky first began using the Nobel, Nobel Biocare, Replace, Nobelreplace, and Nobelguide marks in connection with the sale and promotion of its [dental] goods in February of 200, long after [Plaintiff] Nobel had commenced its substantial use and promotion of its” Nobel trademarks and long after it had registered the trademarks with the USPTO. The complaint alleges infringement of the ‘160 patent and the ‘361 patent. It also alleges infringement of registered trademarks under 15 U.S.C. § 1114. False designation of origin is asserted under section 43(a) of the Lanham Act, 15 U.S.C. § 1125(a) and dilution of trademarks under 15 U.S.C. § 1125(c)(1). California causes of action are asserted for unfair competition under Cal. Bus. & Prof. Code § 17200 and common law trademark infringement. The case is titled Nobel Biocare USA, LLC v. Blue Sky Bio, LLC, CV08-01407 ODW (C.D. California).